Table 1 Demographic and clinical characteristics of the sample (n = 51)

Female/male

27/24

53/47

Primary diagnosis unipolar depression

46

90

Primary diagnosis bipolar depression

5

10

Comorbidity

 Anxiety disorders

21

37

 Autism spectrum disorders

5

10

 Attention deficit hyperactivity disorder

11

22

 Personality disorders

5

10

Supported housing

7

14

Graduated from high school

42

82

Working/studying at least half-time

25

49

Medication

 SSRI

12

24

 SNRI

16

31

 NaSSa

13

25

 Bupropion

5

10

 Tricyclic antidepressants

7

14

 Mood stabilisers^¶

13

25

 Stimulants^¶

9

18

 Antipsychotics‡

11

22

 Olanzapine equivalent dose (mg/day, mean/SD)

4.1

2.4

Age (years)

29.4

9.4

BMI (kg/m²)

26.0

6.3

CAINS score (live)

29.2

7.7

 Motivation and pleasure subscale

21.4

5.9

 Expression subscale

7.7

3.9

BPRS total score (video)

46.6

6.3

 Negative symptoms subscale^†

7.9

3.3

 Positive symptoms subscale^†

3.4

0.9

 Affective symptoms subscale^†

12.4

2.9

 Anxiety and Tension items

6.6

2.2

Maudsley Staging Method score

11.8

12.6

CGI score

4.9

0.8

MADRS-S total

29.9

7.7

MADRS-S anhedonia*

7.4

2.4

MADRS-S anxiety*

3.6

1.3

EQ-VAS score

34.4

15.7

Sheehan Disability Scale score

17.5

7.5

AUDIT score

4.7

4.1

Animal Naming Test**

23.9

6.3

Digit Symbol Substitution Test***

50.5

18.2